Slide
The world’s most advanced bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.

Kerato utilise world-class expertise in tissue engineering to develop bio-engineered corneal products for medical and research applications.

Kerato utilise world-class expertise in tissue engineering to develop bio-engineered corneal products for medical and research applications.

Slide
The world’s most advanced bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.
Our proprietary platform technology allows the fabrication of a fully biosynthetic human cornea in-vitro medical device that reproduces the highly complex nanostructure, molecular composition, shape, transparency, and functional properties of the native human-corneal stroma.

The world’s most advanced
bio-engineered, biomimetic
cornea.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Slide

About Kerato
About Kerato
About Kerato

We are a UK-based biotech company that possesses multi-patented technology. Through our world-class corneal biology research and extensive expertise in tissue engineering and biomaterials, we can develop bio-equivalent tissue that reproduces the complex structure and function of the human cornea.

Our focus is to provide innovative solutions that address medical challenges through our portfolio of Corneal Regenerative Therapies, and an ocular toxicity testing platform that supports commercial research and development activities.

About Kerato
About Kerato

Kerato uses cells and collagen to produce corneas in the laboratory that are comparable to those of human donors. The Company has a dedicated commercial team and has recently appointed a Managing Director, Sarah Greenhalgh, to oversee the development of product offerings and the execution of the product and sales strategy.

Corneal Regenerative
Therapies

We are developing next generation medical devices and therapies aimed at providing novel alternatives to corneal transplantation, addressing the global shortage of human donor tissue for the treatment of corneal blindness.

Ocular Toxicity Testing

Kerato’s Ocular Toxicity testing platform will provide innovative companies with an in-house, high-throughput testing solution providing early indications of the ocular toxicity profile of novel chemical formulations, and reducing the reliance on animal testing.

Helping to reduce the 13m Patients Waiting
for Cornea Transplants

Helping to reduce reliance
on Animal Testing


Latest Feeds

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed doeiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Want to learn more about what we do, and how we could work with your business or research group? Get in touch!

Investment Partner
Scientific Partner
© Kerato Limited 2024. All Rights Reserved 
crossmenu